MEDPLUS HEALTH SERVICES
|
MEDPLUS HEALTH SERVICES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 12.56 | 5.48 | 4.17 | 8.03 | 1,425.40 |
| CEPS(Rs) | 33.42 | 24.24 | 19.42 | 17.94 | 675.81 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 143.22 | 129.47 | 122.44 | 117.89 | 15,220.96 |
| Tax Rate(%) | 18.03 | 10.71 | -6.24 | 19.69 | 33.64 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.09 | 6.51 | 6.08 | 7.54 | 7.32 |
| EBIT Margin(%) | 4.86 | 3.28 | 3.15 | 5.24 | 5.19 |
| Pre Tax Margin(%) | 2.95 | 1.29 | 1.02 | 3.08 | 3.04 |
| PAT Margin (%) | 2.41 | 1.15 | 1.08 | 2.47 | 2.01 |
| Cash Profit Margin (%) | 6.43 | 5.08 | 5.01 | 5.59 | 4.83 |
| Performance Ratios | |||||
| ROA(%) | 4.73 | 2.27 | 1.86 | 4.51 | 4.31 |
| ROE(%) | 9.21 | 4.36 | 3.50 | 9.07 | 10.51 |
| ROCE(%) | 18.22 | 12.19 | 9.56 | 16.56 | 21.69 |
| Asset Turnover(x) | 1.96 | 1.98 | 1.72 | 1.83 | 2.14 |
| Sales/Fixed Asset(x) | 3.18 | 3.28 | 3.39 | 4.13 | 4.38 |
| Working Capital/Sales(x) | 4.91 | 5.47 | 4.60 | 3.57 | 6.16 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.31 | 0.30 | 0.30 | 0.24 | 0.23 |
| Receivable days | 0.90 | 0.84 | 0.58 | 0.54 | 0.69 |
| Inventory Days | 78.76 | 79.52 | 81.27 | 79.28 | 81.18 |
| Payable days | 21.71 | 21.33 | 25.98 | 24.13 | 28.76 |
| Valuation Parameters | |||||
| PER(x) | 60.48 | 125.87 | 156.11 | 125.80 | - |
| PCE(x) | 22.72 | 28.44 | 33.53 | 56.30 | - |
| Price/Book(x) | 5.30 | 5.33 | 5.32 | 8.57 | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.42 | 1.44 | 1.64 | 3.22 | 0.01 |
| EV/Core EBITDA(x) | 15.80 | 19.69 | 22.86 | 37.97 | 0.07 |
| EV/EBIT(x) | 28.87 | 43.29 | 51.30 | 60.53 | 0.11 |
| EV/CE(x) | 5.01 | 5.13 | 5.02 | 4.63 | 0.01 |
| M Cap / Sales | 1.48 | 1.47 | 1.70 | 3.19 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 9.09 | 23.42 | 20.59 | 23.13 | 6.92 |
| Core EBITDA Growth(%) | 34.23 | 25.61 | 2.25 | 27.71 | 66.11 |
| EBIT Growth(%) | 61.55 | 28.24 | -27.38 | 23.63 | 113.38 |
| PAT Growth(%) | 129.09 | 30.88 | -47.10 | 50.08 | 3,417.89 |
| EPS Growth(%) | 129.29 | 31.32 | -48.06 | -99.44 | 1,441.40 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | 0.10 | 0.20 |
| Current Ratio(x) | 3.03 | 2.81 | 3.11 | 2.92 | 2.14 |
| Quick Ratio(x) | 0.87 | 0.48 | 0.71 | 1.28 | 0.46 |
| Interest Cover(x) | 2.54 | 1.65 | 1.48 | 2.42 | 2.41 |
| Total Debt/Mcap(x) | - | - | - | 0.01 | - |
Compare Financial Ratios of peers of MEDPLUS HEALTH SERVICES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDPLUS HEALTH SERVICES | ₹9,360.6 Cr | 2.2% | 1.5% | 15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
MEDPLUS HEALTH SERVICES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDPLUS HEALTH SERVICES | 2.2% |
1.5% |
15.3% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses
